People
“Joining the board will allow me to help guide and influence the development of a product from bench to bedside,” Franchimont told BioSpace. “I look forward to contributing to ongoing discussions on translation from bench science to the clinic, and ultimately to making real differences in the lives of patients.”
In the midst of an international pandemic, three high-profile public health officials are leaving government service.
DBV Technologies aims to fill the peanut allergy treatment gap, especially for highly allergic children, with their low dose epicutaneous immunotherapy (EPIT) patch Viaskin™ Peanut.
With our Diversity and Inclusion Survey, we’ve set out to answer this question in a multitude of areas: religion, sexual orientation, political affiliation, gender identity, and more. Plus, we want to know how you perceive the diversity and inclusiveness of the industry.
Biopharma and life sciences companies bolster their executive ranks and boards with these Movers & Shakers.
While Russian President Vladimir Putin expressed confidence in the preventative medication against the novel coronavirus, scientists from across the globe expressed concern over the lack of available data.
A recent report in the New England Journal of Medicine reveals that the racial and ethnic minority groups most negatively-impacted by COVID-19 are also the least represented in these clinical studies.
Maryland has become a key part of the strategy for Kite, a Gilead company, and its mission to find a cure for cancer.
Biopharma and life sciences companies strengthen their leadership teams and board with these Movers and Shakers.
Although obesity is a known risk factor for death from many conditions, such as cardiovascular disease, experts are now wondering how COVID-19 may impact those who fall into this category.
PRESS RELEASES